Stefan Stremersch holds the Desiderius Erasmus Distinguished Chair of Economics and the Chair of Marketing at the Erasmus School of Economics in Rotterdam (Netherlands). He graduated with the highest honors from Tilburg University (Ph.D. in Business Economics, 2001) and Ghent University (B.A and M.A. in Applied Economics, 1996). <BR> <BR>His current research interests focus on innovation diffusion, marketing of technology and science, marketing strategy, and international marketing. Most of his research is centered on high technology markets (ICT, Telecom, consumer electronics, video games) and pharmaceuticals. His work has appeared in leading scholarly journals such as <i>International Journal of Research in Marketing</i>, <i>Journal of Marketing</i>, <i>Journal of Marketing Research</i>, <i>Marketing Science</i> and <i>Management Science</i>. His work has featured in both national and international press, including <i>The Economist</i>. <BR> <BR>He has won several awards, such as the Harold H. Maynard Best Paper Award of the Journal of Marketing (2002), the J.C. Ruigrok Prize for the most productive young researcher in the social sciences in the Netherlands (awarded only once every 4 years), and the Rajan Varadarajan Early Career Award of the American Marketing Association (in 2008). In 2009, a paper published in <i>Journal of Marketing</i> cited him as the second most prolific scholar in top marketing journals. He is editorial board member of several journals, including <i>Journal of Marketing</i>, and serves as editor of the <i>International Journal of Research in Marketing</i>, together with Don Lehmann. <BR> <BR>Prof. Stremersch teaches marketing strategy, marketing of innovations, and marketing of high technology in IESE's MBA and executive education programs. Before joining IESE, he taught at Duke University (Fuqua), Emory University (Goizueta) and LBS. He has taught in many in-company programs for companies such as 3M, Alcatel-Lucent, and Philips. He has consulted for a number of high-tech companies, such as Philips, Alcatel-Lucent, and Dell, and pharmaceutical companies, such as Merck.